An Update on Microvascular Complications

episode

Type 2 Diabetes: What's new in the RACGP guidelines? not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

A.I. Safety Goes Mainstream + a ‘Hard Fork’ Exit AMA 1h 25m · 18 Sep 2026 · Hard Fork

Layoffs at the Kansas City Star will hurt local communities 15 min · 18 Sep 2026 · Kansas City Today

AWP: Beyond the Exam Room: Purpose, Myopia, and Population Health 54 min · 17 Sep 2026 · EyeCode Media

Planning Commission Meeting - Sep 17, 2026 1h 11m · 17 Sep 2026 · Leesburg Planning Commission

Heritage Commission - Sep 14, 2026 1h 57m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Historic District Review Committee - Sep 14, 2026 1h 36m · 17 Sep 2026 · Loudoun County Board Committees and Advisory Boards

Report any issue

Source

Recorded22 Aug 2021

Publisherracgppodcast.libsyn.com ↗

Handlerec:1460394

Show notes

Dr Gary Deed (GP), Dr Tom Dover (endocrinologist) and Michelle Robins (CDE and nurse practitioner) discuss microvascular complications including all forms of diabetic-related retinopathy, nephropathy and share their perspectives on medications, diabetic foot risk stratification, examination, and referrals. This podcast is intended for healthcare professionals only and should not viewed by anyone but the intended recipient. The views and opinions expressed are those of the presenters and not necessarily those of Sanofi. References: 1. The Royal Australian College of General Practitioners. Management of type 2 diabetes: A handbook for general practice. East Melbourne, Vic: RACGP, 2020.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in